RNF43 and nonpapillary renal cell carcinoma: Based on these results and considering that biomarkers in ccRCC or TAMs are inadequate to comprehensively reflect tumor heterogeneity, we further combined RNF43 expression and CD163+ TAM infiltration to assess patient outcomes after surgery and exhibited superior accuracy than that of RNF43 or CD163 alone.